GlassScriptPhysician profile
Angela Pana
NPI 1932596970
$37,138.40
in general payments reported to CMS, 2019-2025
19 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $928 · 2022: $1,973 · 2023: $1,471 · 2024: $344 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.85 |
| Travel and Lodging | $841.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $19,375.00 | 2019-2020 | |
| Boston Scientific Corporation | $14,155.73 | 2019-2025 | General - Dbs, Bionic Navigator, Vercise |
| Medtronic, INC. | $2,982.68 | 2022-2025 | Percept PC Brainsense, Synchromedii |
| Neurocrine Biosciences, INC. | $120.27 | 2021 | |
| Abbvie INC. | $107.79 | 2022-2024 | |
| Argenx US, INC. | $85.82 | 2023 | Vyvgart |
| Abbott Laboratories | $51.74 | 2022-2023 | Infinity |
| Emd Serono, INC. | $32.60 | 2019 | |
| Genzyme Corporation | $29.38 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $24.74 | 2023 | Nuplazid |
| Kyowa Kirin, INC. | $23.29 | 2021 | |
| Cala Health, INC. | $22.95 | 2023 | Cala Trio |
| Amneal Pharmaceuticals LLC | $20.91 | 2023 | Rytary |
| Jazz Pharmaceuticals INC. | $20.36 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.34 | 2023 | Ultomiris |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $19.71 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $17.53 | 2023 | Dysport |
| Acorda Therapeutics, INC | $15.35 | 2019 | |
| Allergan, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.